{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "SARS-CoV-2",
      "vaccine effectiveness"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35178857",
  "DateCompleted": {
    "Year": "2022",
    "Month": "06",
    "Day": "10"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "09",
    "Day": "03"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "02",
        "Day": "18"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1111/irv.12970"
    ],
    "Journal": {
      "ISSN": "1750-2659",
      "JournalIssue": {
        "Volume": "16",
        "Issue": "4",
        "PubDate": {
          "Year": "2022",
          "Month": "Jul"
        }
      },
      "Title": "Influenza and other respiratory viruses",
      "ISOAbbreviation": "Influenza Other Respir Viruses"
    },
    "ArticleTitle": "mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021.",
    "Pagination": {
      "StartPage": "607",
      "EndPage": "612",
      "MedlinePgn": "607-612"
    },
    "Abstract": {
      "AbstractText": [
        "Reduced COVID-19 vaccine effectiveness (VE) has been observed with increasing predominance of SARS-CoV-2 Delta (B.1.617.2) variant. Two-dose VE against laboratory-confirmed SARS-CoV-2 infection (symptomatic and asymptomatic) was estimated using Cox proportional hazards models with time-varying vaccination status in a prospective rural community cohort of 1266 participants aged\u2009\u226512\u2009years. Between November 3, 2020 and December 7, 2021, VE was 56% for mRNA COVID-19 vaccines overall, 65% for Moderna, and 50% for Pfizer-BioNTech. VE when Delta predominated (June to December 2021) was 54% for mRNA COVID-19 vaccines overall, 59% for Moderna, and 52% for Pfizer-BioNTech."
      ],
      "CopyrightInformation": "\u00a9 2022 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0003-2725-6439"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA."
          }
        ],
        "LastName": "McLean",
        "ForeName": "Huong Q",
        "Initials": "HQ"
      },
      {
        "Identifier": [
          "0000-0001-8470-7190"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA."
          }
        ],
        "LastName": "McClure",
        "ForeName": "David L",
        "Initials": "DL"
      },
      {
        "Identifier": [
          "0000-0003-4627-1378"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA."
          }
        ],
        "LastName": "King",
        "ForeName": "Jennifer P",
        "Initials": "JP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA."
          }
        ],
        "LastName": "Meece",
        "ForeName": "Jennifer K",
        "Initials": "JK"
      },
      {
        "Identifier": [
          "0000-0003-0001-8203"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin, USA."
          }
        ],
        "LastName": "Pattinson",
        "ForeName": "David",
        "Initials": "D"
      },
      {
        "Identifier": [
          "0000-0001-7054-1775"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin, USA."
          }
        ],
        "LastName": "Neumann",
        "ForeName": "Gabriele",
        "Initials": "G"
      },
      {
        "Identifier": [
          "0000-0001-5061-8296"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin, USA."
          }
        ],
        "LastName": "Kawaoka",
        "ForeName": "Yoshihiro",
        "Initials": "Y"
      },
      {
        "Identifier": [
          "0000-0002-0483-9941"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centers for Disease Control and Prevention, Atlanta, Georgia, USA."
          }
        ],
        "LastName": "Rolfes",
        "ForeName": "Melissa A",
        "Initials": "MA"
      },
      {
        "Identifier": [
          "0000-0001-7478-0415"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA."
          }
        ],
        "LastName": "Belongia",
        "ForeName": "Edward A",
        "Initials": "EA"
      }
    ],
    "GrantList": [
      {
        "GrantID": "75D30120C09259",
        "Agency": "US Centers for Disease Control and Prevention",
        "Country": ""
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, U.S. Gov't, P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Influenza Other Respir Viruses",
    "NlmUniqueID": "101304007",
    "ISSNLinking": "1750-2640"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Messenger"
    }
  ],
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prospective Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "RNA, Messenger"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rural Population"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Vaccine Efficacy"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Wisconsin"
    }
  ],
  "CoiStatement": "All authors report no potential conflicts."
}